wait so let me get this straight...
you think the market wont pay much for AHZ until we are making 28million revenue + Vaccines (which by then could be partnered..) + Expanded ADAPT portfolio.
Your dreaming mate.
You value stocks like you would blue chips.
Where in your valuations are growth and potential?
The market will pay for what AHZ can make, not do make.
Yes i agree that AHZ sp has NOT performed, but who cares when investing. (id care if trading, like you)
Bottom line, fundamentals are stronger then ever, and you know it.
wait so let me get this straight... you think the market wont...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.20 |
Change
-0.800(5.71%) |
Mkt cap ! $279.0M | |||
| Open | High | Low | Value | Volume |
| $14.00 | $14.00 | $13.11 | $947.2K | 71.30K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.35 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |